Medicine and Dentistry
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Prostate Specific Membrane Antigen
100%
T Cell
75%
Chemotherapeutic Agent
50%
Drug
50%
Therapeutic Procedure
37%
Combination Therapy
37%
Toxicity
37%
Man
37%
Malignant Neoplasm
25%
Comprehension
25%
Immunotherapy
25%
Patient
12%
Development
12%
Death
12%
Disease
12%
Tumor Microenvironment
12%
Neoplasm
12%
Survival
12%
Experience
12%
Immune Checkpoint Inhibitor
12%
Inpatient
12%
Immune Response
12%
Immunosuppressive Drug
12%
Chimeric Antigen Receptor T-Cell
12%
Cell Therapy
12%
Ligand
12%
Antineoplastic Activity
12%
Tumor Antigen
12%
Chimeric Antigen Receptor T-Cell Immunotherapy
12%
Hematologic Malignancy
12%
Biochemistry, Genetics and Molecular Biology
Membrane
100%
Antigen Antibody Complex
100%
Comprehension
25%
Development
12%
Experience
12%
Survival
12%
Antineoplastic Activity
12%
Immune Response
12%
Dose
12%
Stem Cell
12%
Immune Checkpoints
12%
Clinical Study
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Specific Membrane Antigen
100%
Epithelial Membrane Antigen
12%
Prostate Stem Cell Antigen
12%